Evaluation of CCNU (NSC-79037) used for the prevention of CNS involvement in Burkitt's lymphoma.
D002051:Burkitt Lymphoma / Q000150:complications* / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013997:Time Factors
D009607:Nitrosourea Compounds; D008130:Lomustine